Category: Leukemia

Children’s Hospital at St Francis receives check 28 mins ago

Dozens stood outside on the Children’s playground at St. Francis Hospital as Gold 4 Kids of Tulsa presented a check of $70,00 to the hospital’s staff. Gold 4 Kids, a cancer fundraising organization, focuses on raising money for research, clinical trails, and special projects in order to support the clinical pediatric oncology department at St. Francis hospital.

Celltrion’s Rituxan biosimilar wins Eur…

South Korea’s Celltrion announced Wednesday that the European Medicines Agency has granted sales approval to Truxima, its biosimilar drug referencing Roche’s blockbuster lymphatic cancer drug Rituxan. Truxima is the first ever Rituxan biosimilar to be approved by the European drug regulator, as well as the first ever Europe-approved biosimilar monoclonal antibody used to target cancer.

Lealiifano to coach as cancer comeback continuess

” Wallabies utility back Christian Leali’ifano will take a coaching role with the ACT Brumbies in Super Rugby this season as he considers a return to the rugby field after conquering leukemia. The 29-year-old Leali’fano has gone 100 days since a successful bone marrow transplant and is hopeful of soon playing again at the top level.

Former Four Diamonds Children Inspire Others to Keep Fighting

Both Brady Lucas and Ryan Mourey were diagnosed with leukemia as children and were supported by THON and the Four Diamonds Fund at Penn State Hershey. Today, they are both Penn State students and active in THON, the year-round fundraising effort to fight pediatric cancer that culminates in this weekend’s 46-hour dance marathon.

Fighting cancer with good will and sugar cookies

Volunteers, from left, Anna Ertz, Miranda Vanpelt, Kris Hanks, and Mary Margaret Wagner, far right, decorate cookies Saturday at North Hill Elementary School in Burlington. Dozens of volunteers showed up to decorate cookies in order to raise money for 8-year-old Lilly Timmerman, who was diagnosed in December with myeloid leukemia.

Researchers develop computer machine-learning model to predict remission or relapse in AML patients

Researchers have developed the first computer machine-learning model to accurately predict which patients diagnosed with acute myelogenous leukemia, or AML, will go into remission following treatment for their disease and which will relapse. “It’s pretty straightforward to teach a computer to recognize AML, once you develop a robust algorithm, and in previous work we did it with almost 100 percent accuracy,” said Murat Dundar, senior author of the disease-progression study and associate professor of computer science in the School of Science at Indiana University-Purdue University Indianapolis.

Blood drive in honour of Tom Cameron

… of his time, energy, or other resource within his power. In recent years, however, Cameron dealt with a series of health issues, including a couple of strokes and blood in his lungs. Despite deteriorating health, he never left the helm of Maple …

Novartis Signals Growing Ambitions for CAR-T Cancer Treatments

Novartis AG is pushing ahead with one of its most ambitious cancer therapies, a treatment that the Swiss drugmaker says has blockbuster potential as it extends that technology to a wider pool of tumor-ridden patients. Europe’s second-biggest drugmaker is planning to test its CAR-T treatments — which involve extracting immune cells and genetically engineering them to hunt and kill cancer cells before returning them into the patient’s body — on lethal cancers of the brain, pancreas, colon, ovary and lung.

SSMSE helps in fight against cancer

South St. Marys Street Elementary’s Relay Recess had a special meaning this year as the opening lap of the event was dedicated to fellow student David Smith, who recently diagnosed with leukemia. The event supports the Relay For Life of Elk County along with cancer programs and services in communities throughout the U.S. As many as 250 students participated in the Relay Recess held at the school on Thursday from 3:30-5 p.m. David is a fifth grade student at SSMSE and is currently undergoing treatment at Mercy Hospital in Pittsburgh.

Futility

This past December was a hard month. Bigelow lab where I work, lost our director, Graham Shimmield to colon cancer, and we lost a trustee to cancer, I lost a cousin to ovarian cancer, and a colleague lost her mother, also to cancer.

Student of the Year candidate on how to change a life

It was when he committed to be a Student of the Year candidate for the Leukemia and Lymphoma Society , the world’s largest voluntary health agency dedicated to blood cancer research. Israel, a sophomore at Loyola High School in Los Angeles, is one of 14 L.A. area students accepted into the Students of the Year program.

Johnson & Johnson’s Most Exciting Opportunity

Can cancer drug sales continue to soar? Here’s why cancer drugs could be Johnson & Johnson’s most exciting opportunity in 2017. Global spending on cancer drugs eclipsed $100 billion two years ago, and aging and longer-living populations worldwide have IMS Health projecting that global spending on cancer medicine could hit $150 billion in 2020.

AbbVie: Leveraging Partnerships Play

At the same time AbbVie is able to dictate to smaller-cap biotech stocks and one such partner is Galapagos. Aside from being able to create fruitful relationships with other companies, AbbVie is also very well capable of creating their own breakthrough products.